» Articles » PMID: 2137384

Immunosuppressive Activity of Cyclosporine Metabolites Compared and Characterized by Mass Spectroscopy and Nuclear Magnetic Resonance

Overview
Journal Clin Chem
Specialty Biochemistry
Date 1990 Feb 1
PMID 2137384
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Eight cyclosporine (CsA) metabolites were isolated from the urine of renal-transplant patients by high-pressure liquid chromatography. Structure and purity of the metabolites were assessed by fast atomic bombardment/mass spectroscopy, by proton nuclear magnetic resonance (NMR), and, when the quantity of metabolites permitted, by 13C-NMR. The immunosuppressive activities (I) of the metabolites were tested in three separate in vitro systems: primary and secondary mixed lymphocyte reactions as well as by a mitogen-stimulated system. The I, as measured by comparing the concentration of each metabolite required for 50% inhibition of incorporation of [3H] thymidine, varied among the assay systems, as did the ranking of I among the test systems. In general, the I of most metabolites in all assay systems were less than 10% of that for CsA. Metabolites with single modifications exhibited the greatest I; e.g., that of M-17 was congruent to 16% of that of CsA (potency ratio 0.16) in a secondary mixed lymphocyte reaction. The significance of these findings in relation to therapeutic monitoring of CsA is discussed.

Citing Articles

Recent advances in cyclosporine drug delivery: challenges and opportunities.

Patel D, Wairkar S Drug Deliv Transl Res. 2019; 9(6):1067-1081.

PMID: 31144214 DOI: 10.1007/s13346-019-00650-1.


PharmGKB summary: cyclosporine and tacrolimus pathways.

Barbarino J, Staatz C, Venkataramanan R, Klein T, Altman R Pharmacogenet Genomics. 2013; 23(10):563-85.

PMID: 23922006 PMC: 4119065. DOI: 10.1097/FPC.0b013e328364db84.


Cyclosporin therapeutic drug monitoring--an established service revisited.

Morris R Clin Biochem Rev. 2008; 24(2):33-46.

PMID: 18568053 PMC: 1855625.


[Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].

Sperschneider H, Wagner C, Korn A, Christians U Med Klin (Munich). 1998; 92(10):589-96.

PMID: 9446006 DOI: 10.1007/BF03044784.


Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Faulds D, Goa K, Benfield P Drugs. 1993; 45(6):953-1040.

PMID: 7691501 DOI: 10.2165/00003495-199345060-00007.